GeneDx Holdings Corp [WGS] stock is trading at $97.44, up 7.32%. An important factor to consider is whether the stock is rising or falling in short-term value. The WGS shares have gain 5.82% over the last week, with a monthly amount drifted -13.59%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
GeneDx Holdings Corp [NASDAQ: WGS] stock has seen the most recent analyst activity on August 28, 2024, when Wells Fargo initiated its Equal Weight rating and assigned the stock a price target of $34. Previously, Craig Hallum started tracking the stock with Buy rating on July 10, 2024, and set its price target to $43.
GeneDx Holdings Corp [WGS] stock has fluctuated between $7.72 and $115.60 over the past year. Currently, Wall Street analysts expect the stock to reach $70 within the next 12 months. GeneDx Holdings Corp [NASDAQ: WGS] shares were valued at $97.44 at the most recent close of the market. An investor can expect a potential drop of -28.16% based on the average WGS price forecast.
Analyzing the WGS fundamentals
GeneDx Holdings Corp [NASDAQ:WGS] reported sales of 305.45M for the trailing twelve months, which represents a growth of 66.57%. Gross Profit Margin for this corporation currently stands at 0.61% with Operating Profit Margin at -0.07%, Pretax Profit Margin comes in at -0.17%, and Net Profit Margin reading is -0.17%. To continue investigating profitability, this company’s Return on Assets is posted at -0.12, Equity is -0.25 and Total Capital is -0.06. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.26.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 92.91 points at the first support level, and at 88.39 for the second support level. However, for the 1st resistance point, the stock is sitting at 99.88, and for the 2nd resistance point, it is at 102.32.
Ratios To Look Out For
For context, GeneDx Holdings Corp’s Current Ratio is 3.61. On the other hand, the Quick Ratio is 3.42, and the Cash Ratio is 1.55. Considering the valuation of this stock, the price to sales ratio is 8.95, the price to book ratio is 11.13.
Transactions by insiders
Recent insider trading involved Stueland Katherine, Chief Executive Officer, that happened on Mar 17 ’25 when 10559.0 shares were sold. Chief Executive Officer, Stueland Katherine completed a deal on Mar 13 ’25 to sell 1078.0 shares. Meanwhile, CHIEF FINANCIAL OFFICER Feeley Kevin sold 3749.0 shares on Mar 17 ’25.
